The number of cases of neurological diseases is increasing every year, Parkinson’s disease can double the number of patients by 2030, stroke (stroke) registers over 15 million new cases annually and about 10 million people suffer a head injury each year -cerebral, warns Prof. Dr. Dafin Muresanu, president of the Society for the Study of Neuroprotection and Neuroplasticity.
According to doctor Muresanu, Parkinson’s disease currently affects around 6.3 million people worldwide, including 1.5 million Europeans, but their number is likely to double by 2030, Romania now has over 70,000 patients.
Parkinson’s disease is listed as one of the most representative degenerative neurological disorders in the world, the second most common after Alzheimer’s disease.
Read on A common medicine may protect you from Alzheimer’s or Parkinson’s
In Romania, patients with this condition benefit from specific drug treatment, whose individual monthly costs amount to approximately 3,000 lei.
In some cases of advanced disease, the cost of an operation that can significantly improve the quality of life varies between 30,000 and 80,000 lei, a relatively low cost if we compare it to developed countries where it is between 30,000-50,000 euros. At European level, the total annual cost, which cumulates medical and social spending, is estimated at 14 billion euros.
Stroke registers over 15 million new cases annually, says Professor Muresanu.
According to statistics, approximately one million strokes occur annually in Europe, with studies reporting a population of 500 million. Globally, stroke is the third leading cause of death after cardiovascular disease and cancer.
see how to quickly recognize a stroke
According to the latest World Health Organization report, more than 15 million new cases of stroke have been reported worldwide, about 5 million of these patients die, and another 5 million remain with varying degrees of permanent disability.
Romania is ranked, according to the latest statistics, in the top three European countries in terms of increased incidence of cerebrovascular diseases, as well as cerebrovascular mortality. Clinical data on the survival rate after a stroke seven years after the onset of the disease are worrying: 16% of patients are institutionalized, 20% require walking assistance, 31% require daily care, and 71% have impaired work capacity.
“Recovery of sensory, motor and cognitive functions continues in varying degrees of time, weeks or months, after the onset of a stroke, constituting a promising new therapeutic window. Patient recovery is heterogeneous and is dependent on several factors, such as “More important being the severity of the initial deficit. Other important factors in recovery are the type of stroke, the location and size of the ischemic lesion, the patient’s age, the presence of comorbidities and the treatment of arterial recanalization”, said Prof. Dr. Dafin Muresanu.
The high disease, multiple sclerosis or “1,000-girl disease” it remains one of the diseases whose cause is still unexplained and which affects the young population aged between 20 and 50 years.
“Multiple sclerosis is the second leading cause of disability among young adults, after traumatic brain injury. It affects the young population, being diagnosed, most often, in people aged between 20 and 50 years,” the doctor added.
Craniocerebral traumas are also growing alarmingly worldwide, with approximately 10 million people being diagnosed with this condition each year. The WHO predicts that by 2020, road accidents, the leading cause of head trauma, will become the third largest contributor to the global burden of disease and disability, after cardiovascular disease and depression.
“And this year, our priority for the two events, RoNeuro Brain Days and the International Summer School of Neurology, is to expand educational programs and transpose scientific research into clinical practice,” said Professor Dafin Muresanu, president of the Society for the Study of Neuroprotection and Neuroplasticity. .
He mentioned that a strong emphasis will be placed on the development of methods aimed at neurorecovery of patients.
“Today, the recovery after strokes, craniocerebral or vertebromedullary traumas no longer consists only in physical therapy, the efforts being directed towards the cognitive-emotional side”, added prof.dr. Dafin Muresanu.
The latest news on stroke, Parkinson’s and Alzheimer’s disease, multiple sclerosis or traumatic brain injury (TBI) will be presented soon at Eforie Nord, RoNeuro Brain Days and the International School of Neurology, where researchers and personalities from the academic and university environment, specialists, but also residents from Sweden, Germany, Israel, Great Britain, Austria, Poland, India, Italy, Hungary, the Republic of Moldova and Romania.
The Society for the Study of Neuroprotection and Neuroplasticity (SSNN) was founded in 2005 by an international group of doctors and researchers, at the initiative of Prof. Dr. Dafin F. Muresanu, from the University of Medicine and Pharmacy “Iuliu Hatieganu” in Cluj-Napoca , and Prof. Dr. Ovidiu Bajenaru from the “Carol Davila” University of Medicine and Pharmacy in Bucharest.
SSNN is a scientific organization dedicated to fundamental and clinical research, the creation of a discussion forum to contribute to a better understanding of endogenous neurobiological processes and the development of pharmacological and non-pharmacological therapeutic strategies in the field of neuroprotection and neuroregeneration.
– .
